Initiate one or more expansion cohorts of KO-2806 in combination with cabozantinib in RCC
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Feb 2025
- Due
- 30 Jun 2025
- Checked
- 12 Sep 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Initiate one or more expansion cohorts in combination with cabozantinib in RCC 1H 2025”
What we found
Evidence strength B What the grades mean
Kura repeatedly delayed the RCC expansion cohort guidance from 1H 2025 to 2H 2025, then to 1H 2026, with no evidence it started by the original June 30, 2025 deadline.
-
B Kura Oncology Reports Second Quarter 2025 Financial Results Reaffirmed 2H 2025 guidance for initiating RCC expansion cohorts, still not started.
-
B Kura Oncology Reports Third Quarter 2025 Financial Results Guidance further pushed to 1H 2026 for initiating Phase 1b expansion cohorts in RCC.
-
B Kura Oncology Announces Preliminary Data at ESMO 2025 States dose-escalation ongoing and Phase 1b dose-expansion still only 'planned,' not yet initiated.
-
C Kura Oncology Reports First Quarter 2025 Financial Results Revised guidance to initiate expansion cohorts in 2H 2025, not 1H 2025 as originally promised.
Checked 12 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Merger
- Indicative materiality
- Transformational rules
- Action
- Initiate
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Kura Oncology, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-KURA-000215 · Corrections policy